share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  Mar 5 08:09

Gainers

  • Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 55.9% to $0.07 during Tuesday's pre-market session. The market value of their outstanding shares is at $3.8 million.
  • CASI Pharmaceuticals (NASDAQ:CASI) shares rose 47.68% to $7.51. The company's market cap stands at $100.0 million.
  • Regenxbio (NASDAQ:RGNX) stock moved upwards by 37.17% to $29.3. The market value of their outstanding shares is at $1.3 billion.
  • Apogee Therapeutics (NASDAQ:APGE) stock increased by 36.08% to $56.8. The company's market cap stands at $2.7 billion.
  • Tiziana Life Sciences (NASDAQ:TLSA) shares increased by 19.96% to $0.56. The market value of their outstanding shares is at $56.5 million.
  • Eyenovia (NASDAQ:EYEN) shares moved upwards by 18.85% to $2.71. The market value of their outstanding shares is at $119.5 million.

Losers

  • Lipella Pharmaceuticals (NASDAQ:LIPO) stock decreased by 32.0% to $0.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.3 million.
  • BIMI Intl Medical (NASDAQ:BIMI) stock fell 31.16% to $2.32. The company's market cap stands at $32.4 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares decreased by 30.01% to $2.03. The market value of their outstanding shares is at $2.0 million.
  • Jaguar Health (NASDAQ:JAGX) stock decreased by 15.04% to $0.12. The market value of their outstanding shares is at $6.1 million.
  • Ekso Bionics Holdings (NASDAQ:EKSO) stock fell 14.26% to $1.8. The company's market cap stands at $32.0 million. The company's, Q4 earnings came out yesterday.
  • Cara Therapeutics (NASDAQ:CARA) shares decreased by 11.99% to $0.88. The company's market cap stands at $47.9 million. As per the news, the Q4 earnings report came out yesterday.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment